Induction of cytotoxic T cells and their antitumor activity in mice transgenic for carcinoembryonic antigen Shizuma MizobataKevin TompkinsF. James Primus ORIGINAL ARTICLE Pages: 285 - 295
Development of a new vaccine formulation that enhances the immunogenicity of tumor-associated antigen CaMBr1 Maria Elisa PericoDelia MezzanzanicaSilvana Canevari ORIGINAL ARTICLE Pages: 296 - 304
A low-level expression of human MUC1 mucin enhances lethality of murine tumor cells Gabrielle L. ZimmermannMark J. KrantzB. Michael Longenecker ORIGINAL ARTICLE Pages: 305 - 313
αvβ3 expression on blood vessels and melanoma cells in primary lesions; differential association with tumor progression and clinical prognosis Toshiro KageshitaCarl V. HambySoldano Ferrone ORIGINAL ARTICLE Pages: 314 - 318
Interleukin-13 sensitivity and receptor phenotypes of human glial cell lines: non-neoplastic glia and low-grade astrocytoma differ from malignant glioma Haiyan LiuBarbara S. JacobsBarbara P. Barna ORIGINAL ARTICLE Pages: 319 - 324
Modulation of interleukin-12 synthesis by DNA lacking the CpG motif and present in a mycobacterial cell wall complex Mario C. FilionBenoit FilionNigel C. Phillips ORIGINAL ARTICLE Pages: 325 - 334
Resistance of ex vivo expanded CD3+CD56+ T cells to Fas-mediated apoptosis Michael R. VernerisMartin KornackerRobert S. Negrin ORIGINAL ARTICLE Pages: 335 - 345